2,693 results on '"Kaplan, David E."'
Search Results
152. Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features
153. Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites.
154. Prospective Visual Inspection of the Ventrum of Tongue (VIVOT) Vasculature Predicts the Presence of Esophageal Varices.
155. The Association Between Homelessness and Key Liver-Related Outcomes in Veterans With Cirrhosis.
156. T2 Hepatocellular Carcinoma Exception Policies That Prolong Waiting Time Improve the Use of Evidence-based Treatment Practices
157. Searching for axion forces with precision precession in storage rings
158. Multidisciplinary teams, efficient communication, procedure services, and telehealth improve cirrhosis care: A qualitative study
159. Alpha-Fetoprotein Diagnostics
160. Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma
161. Hepatocellular Cancer Induced by Infection
162. MAGPI: Measurement of Axion Gradients with Photon Interferometry
163. Ursodeoxycholic acid is associated with a reduction in SARS‐CoV‐2 infection and reduced severity of COVID‐19 in patients with cirrhosis
164. The association between mental illness and all-cause mortality in patients with cirrhosis: a Veterans Affairs retrospective cohort study
165. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
166. Association Between Bariatric Surgery and Alcohol Use–Related Hospitalization and All-Cause Mortality in a Veterans Affairs Cohort
167. Immunopathogenesis of Hepatitis C Virus Infection
168. Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
169. Delta hepatitis within the Veterans Affairs medical system in the United States: Prevalence, risk factors, and outcomes
170. Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects
171. Experimental Limit on Nonlinear State-Dependent Terms in Quantum Theory
172. Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
173. Reply
174. Dark Solar Wind
175. Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis
176. Cholestatic Liver Disease Related to Systemic Disorders
177. Development and validation of case‐finding algorithms to identify acute pancreatitis in the Veterans Health Administration
178. Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study
179. Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective
180. Modeling Optimal Clinical Thresholds for Elective Abdominal Hernia Repair in Patients With Cirrhosis
181. Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study
182. Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic
183. COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis
184. Do atoms age?
185. Constraining fundamental constant variations from ultralight dark matter with pulsar timing arrays
186. Major Shifts in Outpatient Cirrhosis Care Delivery Attributable to the COVID‐19 Pandemic: A National Cohort Study
187. Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study
188. Identifying Patient and Provider-specific Gaps in Care Among Patients With Hepatitis B
189. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
190. Efficacy of Sofosbuvir Plus Ribavirin in Veterans With Hepatitis C Virus Genotype 2 Infection, Compensated Cirrhosis, and Multiple Comorbidities
191. Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma.
192. Comparison of infection‐induced and vaccine‐induced immunity against COVID‐19 in patients with cirrhosis
193. Linear slope of serial FIB-4 measurements predicts liver-related complications and correlates with cirrhosis-associated genetic variants among patients with ALT-based NAFLD phenotype
194. Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis
195. 780: DEVELOPMENT AND VALIDATION OF CASE-FINDING ALGORITHMS TO IDENTIFY ACUTE PANCREATITIS IN THE US ELECTRONIC HEALTH RECORD
196. Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
197. 782: COMPARISON OF INFECTION-INDUCED AND VACCINE-INDUCED IMMUNITY AGAINST CORONAVIRUS 2019 IN PATIENTS WITH CIRRHOSIS
198. Mo1165: ANTIBIOTIC EXPOSURE IS ASSOCIATED WITH INCREASED RISK OF ESOPHAGEAL ADENOCARCINOMA
199. Mo1242: RISK FACTORS OF PANCREATIC DUCTAL ADENOCARCINOMA AFTER DIAGNOSIS OF ACUTE PANCREATITIS: A POPULATION-BASED STUDY
200. Genome-wide association study and replication of liver enzyme loci
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.